How To Successfully Treat Myelofibrosis

Medications

Ruxolitinib is a medication approved to treat myelofibrosis. This medication is also referred to as the JAK inhibitor, and it has the ability to not only treat myelofibrosis, but also ease multiple symptoms associated with the disease, such as anemia, enlarged spleen, bone pain, and excessive sweating at night. Ruxolitinib is a form of drug therapy used to block the processes the genetically mutated genes facilitate. Overall, using medication to treat and relieve the symptoms of myelofibrosis can specifically target genetically mutated cells, stopping them from dividing and creating more genetically mutated cells. Additional medications with the ability to effectively relieve an individual’s myelofibrosis symptoms are thalidomide, lenalidomide, and pomalidomide. These can improve blood cell counts, and even relieve symptoms associated with an enlarged spleen.

Keep reading for information on more treatments for myelofibrosis.

Treatments That Target Gene Mutations

There are multiple types of treatments that target gene mutations, such as certain drugs and gene therapy. Using certain drugs, like ruxolitinib, specifically prevents particular genetically mutated cells from dividing and producing more genetically mutated cells. Aside from this method, genetic mutations can also be treated using an experimental technique doctors perform. Gene therapy is designed to introduce improved genetic material into cells to compensate for genetically mutated genes.

Furthermore, gene therapy uses genes to both treat and prevent myelofibrosis. More specifically, myelofibrosis can be treated by using gene therapy because gene therapy replaces mutated genes with healthy genes, and restores the function of the genetically mutated cell. In addition to this, gene therapy can also introduce a new gene into the body to help fight myelofibrosis.

Reveal additional details on the ways to treat myelofibrosis now.